Ozempic: Slim at What Cost?

David vs. Goliath

The surge in popularity of Ozempic, and similar drugs such as Wegovy and Mounjaro, has skyrocketed. But it isn’t just the monetary price tag that’s high. Along with the seemingly magic weight loss, comes a host of reports of medical problems.

In this episode of David v. Goliath, hosts Matt Dolman and Stan Gipe discuss claims involving Ozempic. Originally designed for individuals with type 2 diabetes, Ozempic has taken off for its off-label use as a weight loss medication. However, there’s been a recent slew of claims from people using Ozempic and other GLP-1 drugs involving negative side effects and other health issues from vomiting and incontinence to intestinal blockage and stomach paralysis, some of which require surgical intervention.

Tune in to hear Matt and Stan talk about the latest developments in the weight-loss drug craze and the resulting wave of litigation. Visit the Dolman Law Group website for more information on the Ozempic gallbladder lawsuit and the Ozempic stomach paralysis lawsuit.

Learn More and Connect

☑️ Matt Dolman | LinkedIn

☑️ Stan Gipe

☑️ Dolman Law Group

☑️ Dolman Law Group on LinkedIn, Facebook, Instagram, YouTube

☑️ Subscribe: Apple Podcasts | Spotify | Google Podcasts | YouTube

☑️ Additional Information: New Study Finds Direct Link Between Ozempic and Gastroparesis

The insights and views presented in this podcast are for general information purposes only and should not be taken as legal advice for any individual case or situation. The information presented is not a substitute for consulting with an attorney. Nor does tuning in to this podcast constitute an attorney-client relationship of any kind. Any case result information provided on any portion of this podcast should not be understood as a promise of any particular result in a future case. Dolman Law Group Accident Injury Lawyers: Big firm results, small firm personal attention.